Medindia1d
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
MIT Technology Review2d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Mirage News2d
New Method Identifies Dormant HIV-Carrying Cells
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Technology Networks2d
New Method Identifies Hidden Immune Cells That Harbor HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Mirage News3d
Mount Sinai Unveils Method to Spot Dormant HIV Cells
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Researchers develop method to identify dormant cells that carry HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
News-Medical.Net3d
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
HIV Cases Surge In UP’s Mau District, Officials Cite Unprotected Sex As Key Factor
According to the health department’s recent report, among the 2,394 HIV-positive individuals in Mau, 1,147 are men, 1,151 are women, and 85 are children.
Daily Maverick on MSN4d
US funding cuts imperil African search for HIV vaccine
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...